C-RAD acquires all outstanding shares in Cyrpa International
C-RAD has acquired the remaining 71% of the shares in the Franco-Belgian Cyrpa group. Cyrpa develops innovative laser solutions for patient positioning and virtual simulation within radiation therapy. C-RAD and Cyrpa launched their first joint product for 4D Imaging and Virtual Simulation in 2014. In 2013 C-RAD made a strategic investment to acquire 29% of the shares in Cyrpa with the option to purchase the remaining 71% by 2016. The C-RAD management team decided to bring forward the acquisition to further leverage offering the joint product portfolio to OEM partners and clinical